Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity

Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2007, Vol.13 (4), p.1232-1237
Hauptverfasser: MORGAN, Robert J, SYNOLD, Timothyw, YUNYEN, CHOW, Warren, TETEF, Merry, LIN, Paul, PAZ, Benjamin, KOCZYWAS, Mariana, WAGMAN, Lawrence, CHU, David, FRANKEL, Paul, STALTER, Susan, BIXIN XI, DOROSHOW, James H, LIM, Dean, SHIBATA, Stephen, MARGOLIN, Kim, SCHWARZ, Roderich E, LEONG, Lucille, SOMLO, George, TWARDOWSKI, Przemyslaw
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic agents
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1237
container_issue 4
container_start_page 1232
container_title Clinical cancer research
container_volume 13
creator MORGAN, Robert J
SYNOLD, Timothyw
YUNYEN
CHOW, Warren
TETEF, Merry
LIN, Paul
PAZ, Benjamin
KOCZYWAS, Mariana
WAGMAN, Lawrence
CHU, David
FRANKEL, Paul
STALTER, Susan
BIXIN XI
DOROSHOW, James H
LIM, Dean
SHIBATA, Stephen
MARGOLIN, Kim
SCHWARZ, Roderich E
LEONG, Lucille
SOMLO, George
TWARDOWSKI, Przemyslaw
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_18700025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18700025</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_187000253</originalsourceid><addsrcrecordid>eNqNjLtqw0AQRZcQgxU7_zCNS8HqFak3CU6XIr0Zr0bWmNVK7A4Clflzr3CKlKnu5T7Ok0qyqqrTIn-rnqPXdZPqssi36iWEm9ZZmekyUT9fPQaCTxDPaGHsgJ14nMizjI5idKXBsOCFHcUOpCfxhDKQk3WO7YzOUAsDWr666JkCTJ4H9GwXMKPr4rUFGdcv_CEbnFmWvdp0aAO9_upOHT7ev4-ndMJg0HZ-RYbzg7ics6bWWudV8d_dHaUYVWM</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity</title><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>MORGAN, Robert J ; SYNOLD, Timothyw ; YUNYEN ; CHOW, Warren ; TETEF, Merry ; LIN, Paul ; PAZ, Benjamin ; KOCZYWAS, Mariana ; WAGMAN, Lawrence ; CHU, David ; FRANKEL, Paul ; STALTER, Susan ; BIXIN XI ; DOROSHOW, James H ; LIM, Dean ; SHIBATA, Stephen ; MARGOLIN, Kim ; SCHWARZ, Roderich E ; LEONG, Lucille ; SOMLO, George ; TWARDOWSKI, Przemyslaw</creator><creatorcontrib>MORGAN, Robert J ; SYNOLD, Timothyw ; YUNYEN ; CHOW, Warren ; TETEF, Merry ; LIN, Paul ; PAZ, Benjamin ; KOCZYWAS, Mariana ; WAGMAN, Lawrence ; CHU, David ; FRANKEL, Paul ; STALTER, Susan ; BIXIN XI ; DOROSHOW, James H ; LIM, Dean ; SHIBATA, Stephen ; MARGOLIN, Kim ; SCHWARZ, Roderich E ; LEONG, Lucille ; SOMLO, George ; TWARDOWSKI, Przemyslaw</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Clinical cancer research, 2007, Vol.13 (4), p.1232-1237</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18700025$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>MORGAN, Robert J</creatorcontrib><creatorcontrib>SYNOLD, Timothyw</creatorcontrib><creatorcontrib>YUNYEN</creatorcontrib><creatorcontrib>CHOW, Warren</creatorcontrib><creatorcontrib>TETEF, Merry</creatorcontrib><creatorcontrib>LIN, Paul</creatorcontrib><creatorcontrib>PAZ, Benjamin</creatorcontrib><creatorcontrib>KOCZYWAS, Mariana</creatorcontrib><creatorcontrib>WAGMAN, Lawrence</creatorcontrib><creatorcontrib>CHU, David</creatorcontrib><creatorcontrib>FRANKEL, Paul</creatorcontrib><creatorcontrib>STALTER, Susan</creatorcontrib><creatorcontrib>BIXIN XI</creatorcontrib><creatorcontrib>DOROSHOW, James H</creatorcontrib><creatorcontrib>LIM, Dean</creatorcontrib><creatorcontrib>SHIBATA, Stephen</creatorcontrib><creatorcontrib>MARGOLIN, Kim</creatorcontrib><creatorcontrib>SCHWARZ, Roderich E</creatorcontrib><creatorcontrib>LEONG, Lucille</creatorcontrib><creatorcontrib>SOMLO, George</creatorcontrib><creatorcontrib>TWARDOWSKI, Przemyslaw</creatorcontrib><title>Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity</title><title>Clinical cancer research</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNjLtqw0AQRZcQgxU7_zCNS8HqFak3CU6XIr0Zr0bWmNVK7A4Clflzr3CKlKnu5T7Ok0qyqqrTIn-rnqPXdZPqssi36iWEm9ZZmekyUT9fPQaCTxDPaGHsgJ14nMizjI5idKXBsOCFHcUOpCfxhDKQk3WO7YzOUAsDWr666JkCTJ4H9GwXMKPr4rUFGdcv_CEbnFmWvdp0aAO9_upOHT7ev4-ndMJg0HZ-RYbzg7ics6bWWudV8d_dHaUYVWM</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>MORGAN, Robert J</creator><creator>SYNOLD, Timothyw</creator><creator>YUNYEN</creator><creator>CHOW, Warren</creator><creator>TETEF, Merry</creator><creator>LIN, Paul</creator><creator>PAZ, Benjamin</creator><creator>KOCZYWAS, Mariana</creator><creator>WAGMAN, Lawrence</creator><creator>CHU, David</creator><creator>FRANKEL, Paul</creator><creator>STALTER, Susan</creator><creator>BIXIN XI</creator><creator>DOROSHOW, James H</creator><creator>LIM, Dean</creator><creator>SHIBATA, Stephen</creator><creator>MARGOLIN, Kim</creator><creator>SCHWARZ, Roderich E</creator><creator>LEONG, Lucille</creator><creator>SOMLO, George</creator><creator>TWARDOWSKI, Przemyslaw</creator><general>American Association for Cancer Research</general><scope>IQODW</scope></search><sort><creationdate>2007</creationdate><title>Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity</title><author>MORGAN, Robert J ; SYNOLD, Timothyw ; YUNYEN ; CHOW, Warren ; TETEF, Merry ; LIN, Paul ; PAZ, Benjamin ; KOCZYWAS, Mariana ; WAGMAN, Lawrence ; CHU, David ; FRANKEL, Paul ; STALTER, Susan ; BIXIN XI ; DOROSHOW, James H ; LIM, Dean ; SHIBATA, Stephen ; MARGOLIN, Kim ; SCHWARZ, Roderich E ; LEONG, Lucille ; SOMLO, George ; TWARDOWSKI, Przemyslaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_187000253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MORGAN, Robert J</creatorcontrib><creatorcontrib>SYNOLD, Timothyw</creatorcontrib><creatorcontrib>YUNYEN</creatorcontrib><creatorcontrib>CHOW, Warren</creatorcontrib><creatorcontrib>TETEF, Merry</creatorcontrib><creatorcontrib>LIN, Paul</creatorcontrib><creatorcontrib>PAZ, Benjamin</creatorcontrib><creatorcontrib>KOCZYWAS, Mariana</creatorcontrib><creatorcontrib>WAGMAN, Lawrence</creatorcontrib><creatorcontrib>CHU, David</creatorcontrib><creatorcontrib>FRANKEL, Paul</creatorcontrib><creatorcontrib>STALTER, Susan</creatorcontrib><creatorcontrib>BIXIN XI</creatorcontrib><creatorcontrib>DOROSHOW, James H</creatorcontrib><creatorcontrib>LIM, Dean</creatorcontrib><creatorcontrib>SHIBATA, Stephen</creatorcontrib><creatorcontrib>MARGOLIN, Kim</creatorcontrib><creatorcontrib>SCHWARZ, Roderich E</creatorcontrib><creatorcontrib>LEONG, Lucille</creatorcontrib><creatorcontrib>SOMLO, George</creatorcontrib><creatorcontrib>TWARDOWSKI, Przemyslaw</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MORGAN, Robert J</au><au>SYNOLD, Timothyw</au><au>YUNYEN</au><au>CHOW, Warren</au><au>TETEF, Merry</au><au>LIN, Paul</au><au>PAZ, Benjamin</au><au>KOCZYWAS, Mariana</au><au>WAGMAN, Lawrence</au><au>CHU, David</au><au>FRANKEL, Paul</au><au>STALTER, Susan</au><au>BIXIN XI</au><au>DOROSHOW, James H</au><au>LIM, Dean</au><au>SHIBATA, Stephen</au><au>MARGOLIN, Kim</au><au>SCHWARZ, Roderich E</au><au>LEONG, Lucille</au><au>SOMLO, George</au><au>TWARDOWSKI, Przemyslaw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity</atitle><jtitle>Clinical cancer research</jtitle><date>2007</date><risdate>2007</risdate><volume>13</volume><issue>4</issue><spage>1232</spage><epage>1237</epage><pages>1232-1237</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2007, Vol.13 (4), p.1232-1237
issn 1078-0432
1557-3265
language eng
recordid cdi_pascalfrancis_primary_18700025
source American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antineoplastic agents
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
title Phase I trial of intraperitoneal gemcitabine in thetreatment of advanced malignancies primarily confined to the peritoneal cavity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20I%20trial%20of%20intraperitoneal%20gemcitabine%20in%20thetreatment%20of%20advanced%20malignancies%20primarily%20confined%20to%20the%20peritoneal%20cavity&rft.jtitle=Clinical%20cancer%20research&rft.au=MORGAN,%20Robert%20J&rft.date=2007&rft.volume=13&rft.issue=4&rft.spage=1232&rft.epage=1237&rft.pages=1232-1237&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E18700025%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true